Linex forte in the prevention and treatment of gastrointestinal diseases


Cite item

Full Text

Abstract

The paper discusses the properties of Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. lactis (BB-12) that are active ingredients of linex forte, as well as the results of their experimental and clinical studies in gastroenterology. It states dosing recommendations for the drug to treat gastrointestinal tract diseases in adults and children.

About the authors

E A Ushkalova

Yu Sh Gushchina

References

  1. Maranduba CM, De Castro SB, de Souza GT et al. Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis. J Immunol Res. 2015;2015:931574. doi: 10.1155/2015/931574.
  2. Cuello-Garcia CA, Brożek JL, Fiocchi A et al. Probiotics for the prevention of allergy: A systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2015;136(4): 952-961. doi: 10.1016/j.jaci.2015.04.031.
  3. Zajac AE, Adams AS, Turner JH. A systematic review and meta-analysis of probiotics for the treatment of allergic rhinitis. Int Forum Allergy Rhinol. 2015;5(6):524-532. doi: 10.1002/alr.21492.
  4. Razmpoosh E, Javadi M, Ejtahed HS, Mirmiran P. Probiotics as beneficial agents in the management of diabetes mellitus: a systematic review. Diabetes Metab Res Rev. 2015 May 11. doi: 10.1002/dmrr.2665.
  5. Sun J, Buys N. Effects of probiotics consumption on lowering lipids and CVD risk factors: A systematic review and meta-analysis of randomized controlled trials. Ann Med. 2015;47(6):430-440. doi: 10.3109/07853890.2015.1071872.
  6. Khalesi S, Sun J, Buys N, Jayasinghe R. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension. 2014;64(4):897-903. doi: 10.1161/hypertensionaha.114.03469.
  7. Homayouni A, Bastani P, Ziyadi S et al. Effects of probiotics on the recurrence of bacterial vaginosis: a review. J Low Genit TractDis. 2014;18(1):79-86. doi: 10.1097/lgt.0b013e31829156ec
  8. Chisholm AH. Probiotics in Preventing Recurrent Urinary Tract Infections in Women: A Literature Review. Urol Nurs. 2015;35(1): 18-21, 29.
  9. de Araujo GV, de Oliveira Junior MH, Peixoto DM, Sarinho ES. Probiotics for the treatment of upper and lower respiratory-tract infections in children: systematic review based on randomized clinical trial. J Pediatr(Rio J). 2015;91(5):413-427. doi: 10.1016/j.jped.2015.03.002.
  10. Gungor OE, Kirzioglu Z, Kivanc M. Probiotics: can they be used to improve oral health? Benef Microbes. 2015;6(5):647-656. doi: 10.3920/bm2014.0167.
  11. Shida K, Nomoto K. Probiotics as efficient immunopotentiators: translational role in cancer prevention. Indian J Med Res. 2013;138(5):808-814.
  12. Chong ES. A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action. World J Microbiol Biotechnol. 2014;30(2):351-374. doi: 10.1007/s11274-013-1499-6.
  13. Fond G, Boukouaci W, Chevalier G et al. The «psychomicrobiotic»: Targeting microbiota in major psychiatric disorders: A systematic review. Pathol Biol (Paris). 2015;63(1):35-42. doi: 10.1016/j.patbio.2014.10.003.
  14. Iqbal MZ, Qadir MI, Hussain T et al. Review: probiotics and their beneficial effects against various diseases. Pak J Pharm Sci. 2014;27(2):405-415.
  15. Cruchet S, Furnes R, Maruy A et al. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by latin-american experts. Paediatr Drugs. 2015;17(3):199-216. doi: 10.1007/s40272-015-0124-6.
  16. Picard C, Fioramonti J, Francois A et al. Review article: bifidobacteria as probiotic agents — physiological effects and clinical benefits. AlimentPharmacol Ther. 2005;22(6):495-512.
  17. Беляева Е.А. Микробиота кишечника коренного жителя Центрального федерального округа РФ как основа для создания региональных пробиотических препаратов: Дис. ... канд. биол. наук. Тверь; 2014. Доступно по: vak2.ed.gov.ru/idcUploadAutoref/ renderFile/169815. Ссылка активна на 08.11.2015.
  18. Macfarlane GT, Cummings JH. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ. 1999;318(7189):999-1003.
  19. Magro DO, de Oliveira LM, Bernasconi I et al. Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation. Nutr J. 2014;13:75.
  20. Savard P, Lamarche B, Paradis ME et al. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults. Int J Food Microbiol. 2011;149(1):50-57. doi: 10.1016/j.ijfoodmicro.2010.12.026.
  21. de Vries, MC, Vaughan E, Kleerebezem M et al. Lactobacillus plantarum-survival, functional and potential probiotic properties in the human intestinal tract. Int Dairy J. 2006;16(9):1018-1028.
  22. Klaver FAM et al. The assumed assimilation of cholesterol by lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl Environ Microbiol. 1993;59(4):1120-1124.
  23. Noh DO, Gilliland SE. Influence of bile on beta-galactosidase activity of component species of yogurt starter cultures. J Dairy Sci. 1994;77(12):3532-3537.
  24. Perrin S, Grill JP, Scheneider F. Effects of fructooligosaccharides and their monomeric components on bile salt resistance in three species of bifidobacteria. J Appl Microbiol. 2000;88(6):968-974.
  25. Bedani R, Rossi EA, Isay Saad SM. Impact of inulin and okara on Lactobacillus acidophilus La-5 and Bifidobacterium animalis Bb-12 viability in a fermented soy product and probiotic survival under in vitro simulated gastrointestinal conditions. Food Microbiol. 2013;34(2):382-389. doi: 10.1016/j.fm.2013.01.012.
  26. Hernandez-Hernandez O, Muthaiyan A, Moreno FJ et al. Effect of prebiotic carbohydrates on the growth and tolerance of Lactobacillus. FoodMicrobiol. 2012;30(2):355-361. doi: 10.1016/j.fm.2011.12.022.
  27. Martinez RCR, Aynaou AE, Albrecht S et al. In vitro evaluation of gastrointestinal survival of Lactobacillus amylovorus DSM 16698 alone and combined with galactooligosaccharides, milk and/or Bifidobacterium animalis subsp. lactis Bb-12. Int J Food Microbiol. 2011;149(2):152-158. doi: 10.1016/j.ijfoodmicro.2011.06.010.
  28. Flesch AG, Poziomyck AK, Damin DC. The therapeutic use of symbiotics. Arq Bras Cir Dig. 2014;27(3):206-209.
  29. Juntunen M, Kirjavainen PV, Ouwehand AC et al. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin Diagn Lab Immunol. 2001;8(2):293-296. doi: 10.1128/cdli.8.2.293-296.2001
  30. Collado M, Meriluoto J, Salminen S. In vitro analysis of probiotic strain combinations to inhibit pathogen adhesion to human intestinal mucus. Food Res Int. 2007;40:629-639. doi: 10.1016/j.foodres.2006.11.007
  31. Ouwehand AC, Salminen S, Tölkkö S et al. Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria. ClinDiagn Lab Immunol. 2002;9(1):184-186.
  32. Ouwehand AC, Salminen S, Roberts PJ et al. Disease-dependent adhesion of lactic acid bacteria to the human intestinal mucosa. Clin Diagn Lab Immunol. 2003;10(4):643-646. doi: 10.1128/cdli.10.4.643-646.2003
  33. Kirjavainen PV, Ouwehand AC, Isolauri E, Salminen SJ. The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiology Letters. 1998;167(2):185-189.
  34. Matsumoto M, Tani H, Ono H et al. Adhesive property of Bifidobacterium lactis LKM512 and predominant bacteria of intestinal microflora to human intestinal mucin. Curr Microbiol. 2002;44(3):212-215.
  35. Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol. 1999;65(11):4949-4956.
  36. Plockova M. Inhibition of mold growth and spore production by Lactobacillus acidophilus CH5 metabolites. Bulletin of Food Research (Czech Republic). 1997;36(4):237.
  37. Lin WH, Yu B, Lin CK et al. Immune effect of heat-killed multistrain of Lactobacillus acidophilus against Salmonella typhimurium invasion to mice. Appl Microbiol. 2007;102(1):22-31.
  38. Strus M, Pakosz K, Gościniak A et al. Antagonistic activity of Lactobacillus bacteria strains against anaerobic gastrointestinal tract pathogens (Helicobacter pylori, Campylobacter coli, Campylobacter jejuni, Clostridium difficile). Med Dosw Microbiol. 2001;53(2):133-142.
  39. Hütt J, Shchepetova K, Lõivukene T et al. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. J Appl Microbiol. 2006;100(6):1324-1332.
  40. Wang KY, Li SN, Liu CS et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr. 2004;80(3):737-741.
  41. Kim TS, Hur JW, Yu MA et al. Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J Food Prot. 2003;66(1):3-12.
  42. Vítor JM, Vale FF. Alternative therapies for Helicobacter pylori: probiotics and phytomedicine. FEMS Immunol Med Microbiol. 2011;63(2):153-164. doi: 10.1111/j.1574-695x.2011.00865.x.
  43. Black F, Einarsson K, Lidbeck A et al. Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatmen. Scand J Infect Dis. 1991;23(2):247-254.
  44. Nord CE, Lidbeck A, Orrhage K, Sjöstedt S. Oral supplementation with lactic acid-producing bacteria during intake of clindamycin. Clin MicrobiolInfect. 1997;3(1):124-132.
  45. Sullivan A, Barkholt L, Nord CE. Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteroides fragilis in the intestine. J Antimicrob Chemother. 2003;52(2):308-311.
  46. Macfarlane GT, Cummings JH. Probiotics, infection and immunity. CurrOpin Infect Dis. 2002;15(5):501-506.
  47. Perdigon G, Maldonado Galdeano C, Valdez JC et al. Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr. 2002;56,Suppl 4:S21-26.
  48. Fukushima Y, Kawata Y, Hara H et al. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J FoodMicrobiol. 1998;42(1-2):39-44.
  49. Vissers YM, Snel J, Zuurendonk PF et al. Differential effects of Lactobacillus acidophilus and Lactobacillus plantarum strains on cytokine induction in human peripheral blood mononuclear cells. FEMS Immunol MedMicrobiol. 2010;59(1):60-70. doi: 10.1111/j.1574-695x.2010.00662.x.
  50. Michalkiewicz J, Krotkiewski M, Gackowska L et al. Immunomodulatory effects of lactic acid bacteria on human peripherial blood mononuclear cells. Microbial Ecology in Health and Disease. 07/2009; 15(4):185-192. doi: 10.1080/08910600310022729.
  51. Tejada-Simon MV, Ustunol Z, Pestka JJ. Ex vivo effects of lactobacilli, streptococci, and bifidobacteria ingestion on cytokine and nitric oxide production in a murine model. J Food Prot. 1999;62:162-169.
  52. Holscher HD, Czerkies LA, Cekola P et al. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr. 2012;36(1,Suppl):106S-17S. doi: 10.1177/0148607111430817.
  53. Kabeerdoss J, Devi RS, Mary RR, Prabhavathi D, Vidya R, Mechenro J, Mahendri NV, Pugazhendhi S, Ramakrishna BS. Effect of yoghurt containing Bifidobacterium lactis Bb12(R) on faecal excretion of secretory immunoglobulin A and human beta-defensin-2 in healthy adult volunteers. Nutr J. 2011;10:138. doi: 10.1186/1475-2891-10-138.
  54. Mohan R, Koebnick C, Schildt J et al. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res. 2008;64(4):418-422. doi: 10.1203/pdr.0b013e318181b7fa.
  55. Haschke F, Wang W, Guozai Ping et al. Clinical trials prove the safety and efficacy of the probiotic strain Bifidobacterium Bb12 in follow-up formula and growing milks. Monatsschrift Kinderheilkude. 1998;146(1):26. doi: 10.1007/pl00014763
  56. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet. 1994;344(8929):1046-1049.
  57. Phuapradit P, Varavithya W, Vathanophas K et al. Reduction of rotavirus infection in children receiving bifidobacteria-supplemented formula. J Med Assoc Thai. 1999;82,Suppl 1:S43-48.
  58. Chouraqui JP, Van Egroo LD, Fichot MC. Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr. 2004;38(3):288-292.
  59. Hatakka K, Savilahti E, Pönkä A, Meurman JH et al. Effect of long term consumption of probiotic milk on infections in children attending daycare centers: a double blind, randomized trial. BMJ. 2001;322(7298):1327.
  60. Taipale T, Pienihäkkinen K, Isolauri E et al. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br JNutr. 2011;105(3):409-416. doi: 10.1017/s0007114510003685.
  61. Taipale TJ, Pienihäkkinen K, Isolauri E et al. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatr Res. 2015 Sep 15. doi: 10.1038/pr.2015.174.
  62. Rautava S, Salminen S, Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy — a randomised, double-blind, placebo-controlled study. Br J Nutr. 2009;101(11):1722-1726. doi: 10.1017/s0007114508116282.
  63. Langhendries JP, Detry J, Van Hees J et al. Effect of a fermented infant formula containing viable bifidobacteria on the fecal floracomposition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr. 1995;21(2):177-181.
  64. Alander M, Mättö J, Kneifel W et al. Effect of galacto-oligosaccharide supplementation on human faecal micro-flora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract. Int.Dairy J. 2001;11:817-825. doi: 10.1016/s0958-6946(01)00100-5.
  65. Schiffrin EJ, Rochat F, Link-Amster H et al. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J DairySci. 1995;78(3):491-497.
  66. Link-Amster H, Rochat F, Saudan KY et al. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol. 1994;10(1):55-63.
  67. Fox MJ, Ahuja KD, Robertson IK et al. Can probiotic yogurt prevent diarrhoea in children on antibiotics? A double-blind, randomised, placebo-controlled study. BMJ Open. 2015;5(1): e006474. doi: 10.1136/bmjopen-2014-006474.
  68. de Vrese M. Effects of probiotic bacteria on gastrointestinal symptoms, Helicobacter pylori activity and antibiotics-induced diarrhea. Gastroenterology. 2003;124:A560. doi: 10.1016/s0016-5085(03)82836-6.
  69. de Vrese M, Feindt F, Kristen H et al. Nachweis probiotischer Eigenschaften von Milchsäurebakterien — Helicobacter pylori Infektionen als Untersuchungsmodell. BMVEL-Forschungsreport. 2003;2:43-49.
  70. Black FT, Andersen PL. Ørskov J, Ørskov F, Gaarslev K, Laulund S. Prophylactic efficacy of lactobacilli on travelers diarrhea. Travel Medicine. Berlin: Heidelberg: Springer; 1989:333-335. doi: 10.1007/978-3-642-73772-5-70.
  71. Chatterjee S, Kar P, Das T et al. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea. J Assoc Physicians India. 2013;61(10):708-712.
  72. Clauson ER, Crawford P. What you must know before you recommend a probiotic. J Fam Pract. 2015;64(3):151-155.
  73. de Vrese M, Kristen H, Rautenberg P et al. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. J Dairy Res. 2011;78(4):396-403. doi: 10.1017/s002202991100063x.
  74. Sheu BS, Wu JJ, Lo CY et al. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2002;16(9):1669-1675.
  75. Salminen E, Elomaa I, Minkkinen J et al. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol. 1988;39(4):435-437.
  76. Chitapanarux I, Chitapanarux T, Traisathit P et al. Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol. 2010;5:31. doi: 10.1186/1748-717x-5-31.
  77. Laake KO, Bjørneklett A, Aamodt G et al. Outcome of four weeks’ intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis. Scand J Gastroenterol. 2005;40(1):43-51.
  78. Alm L. Acidophilus milk for therapy in gastrointestinal disorders. Nahrung. 1984;28(6-7):683-684.
  79. Alm L, Ryd-Kjellen E, Setterberg G and Blomquist L. Effect of a new fermented milk product «CULTURA» on constipation in geriatric patients. 1st Lactic Acid Bacteria Computer Conference Proceedings. Horizon Scientific Press, Norfolk, England 1993. Available at: http://trove.nla.gov.au/work/10916224?q&versionId=12759593. Accessed November 8, 2015.
  80. Vanderhoof JA, Young RJ. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 1998;7(3):323-332.
  81. World Gastroenterology Organisation Practice Guideline. Probiotics and prebiotics May 2008.
  82. Jiang T, Savaiano DA. Lactobacilli supplementation and short chain fatty acid (SCFA) production by human fecal bacteria grown in continuous culture. Gastroenterology. 1995;108(4):A293.
  83. Waller PA, Gopal PK, Leyer GJ et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011;46(9):1057-1064. doi: 10.3109/00365521.2011.584895.
  84. Yang YX, He M, Hu G et al. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World JGastroenterol. 2008;14(40):6237-6243.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies